Christopher Calhoun - Macropore Biosurgery Inc (mrpof.pk)

Healthcare >> CEO Interviews >> October 17, 2003

Dr. Marc H. Hedrick is President and CEO of Cytori Therapeutics Inc. Dr. Hedrick was trained as a general, vascular and craniofacial surgeon who left his clinical practice and tenured faculty appointment at UCLA in 2003 after founding StemSource, Inc. StemSource later became Cytori, a leading U.S. public company specializing in stem cell therapies. Previously, Dr. Hedrick was a tenured Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles — UCLA. While at UCLA, Dr. Hedrick also directed the Laboratory of Regenerative Bioengineering and Repair. Dr. Hedrick’s research encompassed many areas, including tissue engineering, stem cell biology and fetal surgery. Dr. Hedrick has published over 200 scientific abstracts, papers and book chapters, and received research funding from a variety of private and governmental agencies, including the National Institutes of Health. In addition, he has 23 published or issued patents around the world, and both he and his work have been featured prominently in numerous leading periodicals and media outlets. Dr. Hedrick obtained his undergraduate degree from Southern Methodist University, his medical degree from the University of Texas Southwestern Medical School and his Master of Business Administration from the UCLA Anderson School of Management. He completed residencies in plastic surgery at UCLA, and general and vascular surgery at the University of Oklahoma. He has also completed fellowships in craniofacial surgery at University of Pittsburgh and fetal surgery at the University of California, San Francisco. Dr. Hedrick resides in Encinitas, California, is married to Tracey Carole Hedrick and has two children, Catherine and Marc II. Profile

CHRISTOPHER J. CALHOUN has served as Vice Chairman, Secretary, Director, President and Chief Executive Officer of MacroPore Biosurgery, Inc., since 1997. He is a company co-founder and a co-inventor on multiple US and international patents used for the company's bioresorbable implant technology. These inventions include bioresorbable polymers for skeletal repair and regeneration, and implant surfaces for tissue guidance and postsurgical scar tissue reduction. He also is named as an inventor on various US and international patents pending for medical devices and implant instrumentation. Mr. Calhoun was previously involved in research and management for the Plastic Surgery Bone Histology and Histometry Laboratory at the University of California, San Diego. He is a co- founder and Board member of Leonardo MD, and previously served on the Board of Directors of StemSource, Inc. Mr. Calhoun received a BA from the University of California, San Diego and an MBA from the University of Phoenix. Profile

TWST: Would you give us an overview of MacroPore Biosurgery, its

operations and its products?

Mr. Calhoun: (Vice Chairman, President & CEO): MacroPore Biosurgery

essentially has two

Join for free to read a longer excerpt or purchase this article

Christopher Calhoun – Macropore Biosurgery Inc (mrpof.pk)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS